Weight loss drug Ozempic was launched in India on Friday, with 0.25mg doses priced at $24.35 a week. Pharmaceutical company ...

Novo Nordisk has officially launched Ozempic in India for diabetes care. Here's how the injectable works, its dosage options, ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 (approx ₹ 2,200) per week, as it seeks ...

Danish pharmaceutical company, Novo Nordisk, has launched its successful diabetes and weight-loss drug, Ozempic, in India ...

Ozempic has been approved for type-2 diabetes, while Novo Nordisk’s other global blockbuster Wegovy is targeted at obesity.

The drug is marketed globally by Novo Nordisk as Ozempic for Type 2 diabetes and for obesity, and has been at the centre of a ...

By Rishika Sadam Dec 12 (Reuters) - Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per ...

The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...

By Rishika Sadam Dec 12 (Reuters) - Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on ...

Ozempic, a once-weekly injectable approved by the U.S. Food and Drug Administration in 2017 for type 2 diabetes, has become a ...

The 41-year-old is hitting back at the online chatter surrounding her dramatic weight loss, saying she’s been struggling to eat since the death of her father, heavy metal icon Ozzy Osbourne.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.